Star Staining fluorescent-labeled products are developed by a new-generation site-specific labeling technology with "Star Standard" quality at ACROBiosystems. These products are uniquely designed to fully meet diverse quality control needs for CAR-positive rate detection. 

AcroBiosystems is dedicated to developing a series of anti-Linker antibodies, such as G4S Linker and Whitlow/218 Linker, covering various fluorescent labels including PE, APC, and Alexa Fluor™, providing groundbreaking solutions for CAR molecule characterization and functional testing. Additionally, they offer premium-grade anti-Linker antibodies and magnetic beads, ideal for key applications like cell activation and sorting. 

Provide culture media suitable for various types of cell cultures such as T cells, NK cells, CAR-T, CIK, CAR-NK, etc; Chemically defined, no serum, animal origin-free, higher expansion efficiency!

Leveraging global pharmacopeial standards and regulatory frameworks, SAFENSURE™ delivers a next-generation safety QC solution for endotoxin, mycoplasma, and sterility testing. By integrating recombinant technologies and rapid methods, it enhances sensitivity, robustness, and sustainability, enabling end-to-end quality control from raw materials to final release, accelerating CMC timelines, and supporting efficient, compliant biopharmaceutical manufacturing. 

• Recombinant Factor C Endotoxin Detection Kit
• Recombinant Factor C Endotoxin Detection Kit (High Sensitivity)Coming Soon
• LER Sample Dilution Buffer
• Endotoxin-Free Glass Test Tubes
• Mycoplasma DNA Sample Preparation Kit (Magnetic beads)
• Mycoplasma Rapid Detection Kit (qPCR)
• Sterility Sample Preparation Kit (Magnetic beads)
• Sterility Rapid Detection Kit (qPCR)
• Automated Nucleic Acid Extraction System
• Nuclease-Free Water
• 96 V-Bottom Deep-well Plate
• 8-Strip V-Bottom Tip Comb

A variety of disposable sterile transfer kits are provided, featuring weldable tubing designs that enable safe and convenient connection to containers such as medium flasks, slant bottles, and vials. These kits effectively facilitate the sterile preparation and transfer of media and cytokines, further enhancing the integrity and controllability of the production process.

Manufacturing biologics is a complex process that can introduce a wide variety of residues that can compromise the safety of the final therapeutic. Use AcroBiosystems kits to detect for residues and ensure that your therapy is ready for the clinical stage. 

• Residual Host Cell DNA Detection Kits
• Residual Plasmid DNA Quantitation Kit
• RNase / DNase Detection Kits
• Residual dsRNA ELISA Kit
• Residual T7 RNA polymerase ELISA Kit
• Residual BSA ELISA Kit
• Residual Antibiotics Detection Kits
• Residual HIV-1 p24 ELISA Kit
• Residual Cell Culture Materials Detection Kits
• Human Laminin Quantitative ELISA Kit
• CGT CMC Manufacturing Process Residue Detection Solutions

A series of tools for cell activation, such as classical antibodies, magnetic beads, and specific antigen coupled magnetic beads, have been validated at the cellular level and can efficiently stimulate and expand target cells, better assisting the development process of cell therapy drugs.

Leveraging AcroBiosystems flow cytometry analysis platform, they are dedicated to providing precise drug characterization and activity analysis solutions to advance drug quality control and clinical evaluation. 

• Human Th1/Th2 Cytokine Kit
• Human TBNK 6-color Cocktail Flow Panel
• Anti-Linker Antibodies
• Anti-FMC63 scFv Antibodies
• Anti-C11D5.3 scFv Antibodies
• MHC Tetramer
• Antibody Labeling Kit
• Single/Multiplex Cytokine Flow Cytometry Analysis Platform
• Cell Phenotyping Flow Cytometry Analysis Platform
• Star Staining New-generation Site-specific Labeling Platform
• Fluorescent Labeled CAR Target Protein

Gene editing technology is widely used in gene therapy and CAR cell therapy, typically using delivery systems such as viral vectors to deliver specific genetic material into specific target cells, modifying the expression of individual genes or repairing abnormal genes. We focus on the CGT field and provide high-quality gene editing related tools.

AcroBiosystems provides high-quality fluorescent-labeled proteins for precise antibody density quantification on Ab-LNPs, supporting the development of In Vivo CAR cell therapies. 

• Alexa Fluor™ 488-Labeled Human CD3 epsilon Protein, His Tag
• Alexa Fluor™ 488-Labeled Human CD8 alpha Protein, His Tag
• Alexa Fluor™ 488-Labeled Human CD5 Protein, His Tag Star Staining
• Alexa Fluor™ 488-Labeled Human CD4 Protein, His Tag Star Staining
• Alexa Fluor™ 488-Labeled Human CD7 Protein, His Tag Star Staining

Sample cleanup is a necessary part of manufacturing designed to prepare the final therapeutic for patient safety and successful IND application. Explore AcroBiosystems nucleases designed to remove nucleic acid residues.

The ELISA Kit is a ready-to-use immunoassay kit, validated with biological samples. AcroBiosystems offers quantitative kits for various targets, including cytokines and biomarkers, ensuring accurate, specific, and reliable results. 

• IFN-γ ELISA Kit
• IL-2 ELISA Kit
• Cytokines ELISA Detection Kits
• Biomarkers ELISA Detection Kits

AcroBiosystems various solutions aim to provide customers with a more comprehensive and high-quality service experience, and accelerate the commercialization of CGT drugs!

• Overexpression cell lines
• Gene knockout cell lines
• Cell Line Customization Service
• Functional Cell Line Commercial License Support Service
• One-stop cell line solutions

AcroBiosystems has an experienced Custom GMP-grade Products team and a high standard GMP factory, which can provide you with strong support. It has advantages such as compliance with regulatory requirements, audit-friendly, high customization and flexible adaptation capabilities, and strong application development support.

The GMP-Resilient Supply aims to provide global customers with more flexible, resilient, low-risk, high-quality, and professionally supported solutions, accelerating the development and launch process of CGT biopharmaceuticals.